Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... development of a therapeutic vaccine for Hepatitis C, and from the National Institute of Allergy and Infectious Diseases (via the University of New Mexico) for the development of a ...
2009 NOV 2 ... This work was funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human ... Argos Therapeutics announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ...
2009 NOV 2 ... Once supply catches up with the immediate demand for H1N1 "swine" flu vaccine, some allergy patients who could benefit from the vaccine may needlessly avoid it due to confusion ...
2009 NOV 2 ... Institute of Medical Sciences - U.S. and Thai components, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, sanofi pasteur, ... Detailed results from the Prime-Boost HIV Vaccine Clinical Trial involving more than 16,000 adult volunteers in Thailand show that an ...
2009 NOV 16 ... vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This ...
2009 NOV 16 ... and expand care. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, and colleague Gregory K. Folkers call for increased global ... Although much attention has focused on the scientific obstacles to developing an HIV vaccine, the Massachusetts Institute of Technology's Jeffrey E. Harris contends that the ...
2009 NOV 30 ... to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. "For ... women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National ...
Subject: NIH/National Institute of Allergy and Infectious Diseases
2009 NOV 23 ... announced it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to ... Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of ...
2009 DEC 1 ... SAN DIEGO - (November 16, 2009) Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some ... would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease. "What ...
Subject: La Jolla Institute for Allergy and Immunology
2009 NOV 1 ... a Small Business and Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant ... preclinical research program for the respiratory syncytial virus (RSV) particle-based vaccine. RSV is the most commonly identified cause of lower respiratory tract illnesses in ...
2009 NOV 29 ... Government, Pediatrics, Political Analysis, Politics, Allergies, Allergy Medicine, Asthma, Biotechnology, Flu Vaccines, H1N1 Virus, Health Policy, Heart Disease, ... Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. The poll, which examines the ...
2009 NOV 2 ... while being nonreactogenic. We describe such a vaccine for the treatment of cat allergy, consisting of the major cat allergen Fel d1 coupled to bacteriophage Q beta-derived ...
2009 NOV 23 ... from polyclonal antibodies," wrote S.E. Hensley and colleagues, National Institute of Allergy and Infectious Diseases. The researchers concluded: "We propose that in ... To understand this phenomenon, we passaged virus in mice immunized with influenza vaccine," scientists in the United States report. "Neutralizing antibodies ...
2009 NOV 30 ... acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), ... of our academic and industry consortium members brings impressive expertise to our vaccine stabilization program," said Dr. Robert N. Brey, PhD, Chief Scientific Officer of ...
2009 NOV 30 ... was primarily due to revenue from VGX's contracts with the National Institute of Allergy and Infectious Diseases ("NIAID") and PATH Malaria Vaccine Initiative ("MVI") of ...
2009 NOV 17 ... four oral presentations and one poster presentation at this year's American College of Allergy, Asthma and Immunology's Annual Scientific Meeting in Miami, Florida. Michelle Altrich, ... with recurrent infections for suspected immunodeficiency routinely involves the use of vaccine challenge tests. This presentation will cover a new way to evaluate the immune system so ...
